Axsome Thera (AXSM)
$62.63
1.12 (1.82%)
AXSM Stock Quote Delayed 30 Minutes
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.73B
PE Ratio
-17.74
EPS
-3.53
Volume (Avg. Vol.)
287,188
Day's Range
$61.01 - $62.87
52-Week Range
$20.63 - $82.00
Dividend & Yield
N/A (N/A)
AXSM Stock Predictions, Articles, and Axsome Thera News
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Why Is Axsome Therapeutics (AXSM) Stock Up 30% Today?
Biopharmaceutical company AXSM stock is getting a huge lift from news the FDA has approved its depression treatment.
Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's a new week and that means it's time for us to start it off with a look at the biggest pre-market stock movers for Monday!
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on Covid-19 and cryptocurrency stocks with the infrastructure bill up for a vote.
AXSM Stock: The Big FDA News Giving Axsome Therapeutics a Boost
AXSM stock is gaining on Monday after the FDA granted its new drug application priority review. Here's what you should know now.
Axsome Therapeutics News: AXSM Stock Rockets 76% on Depressive Disorder Drug Results
Axsome Therapeutics (AXSM) news for Monday about results from the company's Phase 3 Trial of AXS-05 has AXSM stock rocketing higher.
Axsome Therapeutics: Do Not Buy AXSM Stock After Its Monster Rally
No longer a penny stock, Axsome Therapeutics (AXSM) surged past $8 a share on news that its AXS-05 treatment affected a 17.2-point drop in patients on the Montgomery-Asbert Depression Rating Scale. But is it a buy?
